Avalon GloboCare Management
Management criteria checks 4/4
Avalon GloboCare's CEO is David Jin, appointed in Sep 2016, has a tenure of 7.67 years. total yearly compensation is $330.00K, comprised of 100% salary and 0% bonuses, including company stock and options. directly owns 13.91% of the company’s shares, worth $381.00K. The average tenure of the management team and the board of directors is 7.6 years and 5.8 years respectively.
Key information
David Jin
Chief executive officer
US$330.0k
Total compensation
| CEO salary percentage | 100.0% |
| CEO tenure | 7.7yrs |
| CEO ownership | 13.9% |
| Management average tenure | 7.6yrs |
| Board average tenure | 5.8yrs |
Recent management updates
Recent updates
We Think Some Shareholders May Hesitate To Increase Avalon GloboCare Corp.'s (NASDAQ:ALBT) CEO Compensation
Oct 06
We Think Avalon GloboCare (NASDAQ:AVCO) Has A Fair Chunk Of Debt
Sep 29Would Avalon GloboCare (NASDAQ:AVCO) Be Better Off With Less Debt?
Jun 01Does Avalon GloboCare (NASDAQ:AVCO) Have A Healthy Balance Sheet?
Feb 23Here's Why Avalon GloboCare (NASDAQ:AVCO) Can Afford Some Debt
Oct 14Avalon Globocare to acquire SenlangBio in all-stock deal
Jun 14Is Avalon GloboCare (NASDAQ:AVCO) A Risky Investment?
May 15A Look At Avalon GloboCare's (NASDAQ:AVCO) Share Price Returns
Feb 25Have Insiders Been Buying Avalon GloboCare Corp. (NASDAQ:AVCO) Shares This Year?
Jan 30Is Avalon GloboCare (NASDAQ:AVCO) Using Too Much Debt?
Jan 04What Percentage Of Avalon GloboCare Corp. (NASDAQ:AVCO) Shares Do Insiders Own?
Nov 30CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | US$330k | US$330k | -US$17m |
| Sep 30 2023 | n/a | n/a | -US$10m |
| Jun 30 2023 | n/a | n/a | -US$13m |
| Mar 31 2023 | n/a | n/a | -US$13m |
| Dec 31 2022 | US$360k | US$360k | -US$12m |
| Sep 30 2022 | n/a | n/a | -US$12m |
| Jun 30 2022 | n/a | n/a | -US$8m |
| Mar 31 2022 | n/a | n/a | -US$9m |
| Dec 31 2021 | US$360k | US$360k | -US$9m |
| Sep 30 2021 | n/a | n/a | -US$10m |
| Jun 30 2021 | n/a | n/a | -US$11m |
| Mar 31 2021 | n/a | n/a | -US$12m |
| Dec 31 2020 | US$1m | US$360k | -US$13m |
| Sep 30 2020 | n/a | n/a | -US$15m |
| Jun 30 2020 | n/a | n/a | -US$16m |
| Mar 31 2020 | n/a | n/a | -US$17m |
| Dec 31 2019 | US$935k | US$540k | -US$18m |
| Sep 30 2019 | n/a | n/a | -US$15m |
| Jun 30 2019 | n/a | n/a | -US$14m |
| Mar 31 2019 | n/a | n/a | -US$11m |
| Dec 31 2018 | US$400k | US$400k | -US$8m |
| Sep 30 2018 | n/a | n/a | -US$7m |
| Jun 30 2018 | n/a | n/a | -US$5m |
| Mar 31 2018 | n/a | n/a | -US$4m |
| Dec 31 2017 | US$200k | US$200k | -US$3m |
Compensation vs Market: David's total compensation ($USD330.00K) is below average for companies of similar size in the US market ($USD663.90K).
Compensation vs Earnings: David's compensation has been consistent with company performance over the past year.
CEO
David Jin (55 yo)
7.7yrs
Tenure
US$330,000
Compensation
Dr. David K. Jin, M.D., Ph D., serves as the Chief Executive Officer and President of Avalon Globocare Corp since September 14, 2016. Dr. Jin is a Senior Translational Scientist at the Howard Hughes Medica...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 7.7yrs | US$330.00k | 13.91% $ 381.0k | |
| Chief Financial Officer | 7.3yrs | US$350.00k | 0% $ 0 | |
| COO, Chief Marketing Officer & Secretary | 7.6yrs | US$280.24k | 4.64% $ 127.0k |
7.6yrs
Average Tenure
55yo
Average Age
Experienced Management: ALBT's management team is seasoned and experienced (7.6 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 7.7yrs | US$330.00k | 13.91% $ 381.0k | |
| Member of Scientific & Clinical Advisory Board | 5.1yrs | no data | no data | |
| Independent Director | 5.8yrs | US$103.67k | 0% $ 0 | |
| Independent Director | 5.8yrs | US$125.27k | 0% $ 0 | |
| Member of Scientific & Clinical Advisory Board | no data | no data | no data | |
| Director | 6.5yrs | US$38.05k | 0% $ 0 | |
| Independent Director | 5.9yrs | US$93.67k | 0% $ 0 | |
| Independent Director | 1.3yrs | US$91.76k | 0% $ 0 | |
| Chairman of the Board | 7.6yrs | US$100.00k | 32.27% $ 883.8k | |
| Head of Scientific & Clinical Advisory Board | 5.8yrs | no data | no data | |
| Member of Scientific & Clinical Advisory Board | no data | no data | no data | |
| Member of Scientific & Clinical Advisory Board | no data | no data | no data |
5.8yrs
Average Tenure
59.5yo
Average Age
Experienced Board: ALBT's board of directors are considered experienced (5.8 years average tenure).